The different association between serum ferritin and mortality in hemodialysis and peritoneal dialysis patients using Japanese nationwide dialysis registry

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Maruyama, Yukio ^a   Yokoyama, Keitaro ^a   Yokoo, Takashi ^a   Shigematsu, Takashi ^b   Iseki, Kunitoshi ^b   Tsubakihara, Yoshiharu ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Scientific Academic Committee of the Japanese Society for Dialysis Therapy   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; TRANSFERRIN;

AGED; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC GLOMERULONEPHRITIS; DIABETIC NEPHROPATHY; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HUMAN; INFECTION; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROSCLEROSIS; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; BLOOD; COHORT ANALYSIS; DIABETIC NEPHROPATHIES; GLOMERULONEPHRITIS; JAPAN; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; POLYCYSTIC KIDNEY DISEASES; PROCEDURES; TREATMENT OUTCOME;

AGED; ANEMIA; COHORT STUDIES; DIABETIC NEPHROPATHIES; FEMALE; FERRITINS; GLOMERULONEPHRITIS; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROSCLEROSIS; PERITONEAL DIALYSIS; POLYCYSTIC KIDNEY DISEASES; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; TRANSFERRIN; TREATMENT OUTCOME;

EID: 84957922990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143430     Document Type: Article

References (30)

1. Langston RD, Presley R, Flanders WD, McClellan WM. Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney Int. 2003;64(4):1398-405. PMID: 12969159.
2. Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, et al. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial. 2010;14(3):240-75. PMID: 20609178. doi: 10.1111/j.1744-9987.2010.00836.x
3. Coyne DW. Hepcidin: clinical utility as a diagnostic tool and therapeutic target. Kidney Int. 2011;80(3):240-4. PMID: 21677632. doi: 10.1038/ki.2011.141
4. Maruyama Y, Yokoyama K, Yamamoto H, Nakayama M, Hosoya T. Do serum hepcidin-25 levels correlate with oxidative stress in patients with chronic kidney disease not receiving dialysis? Clin Nephrol. 2012;78(4):281-6. PMID: 22541685. doi: 10.5414/CN107424
5. Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG. Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol. 2005;16(10):3070-80. PMID: 16033854.
6. Kuragano T, Matsumura O, Matsuda A, Hara T, Kiyomoto H, Murata T, et al. Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients. Kidney Int. 2014;86(4):845-54. PMID: 24759150. doi: 10.1038/ki.2014.114
7. Hasuike Y, Nonoguchi H, Tokuyama M, Ohue M, Nagai T, Yahiro M, et al. Serum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya study. Clin Exp Nephrol. 2010;14(4):349-55. PMID: 20467772. doi: 10.1007/s10157-010-0288-x
8. Cuevas X, Garcia F, Martin-Malo A, Fort J, Llados F, Lozano J, et al. Risk factors associated with cardiovascular morbidity and mortality in Spanish incident hemodialysis patients: two-year results from the ANSWER study. Blood Purif. 2012;33(1-3):21-9. PMID: 22134224. doi: 10.1159/000332395
9. Pollak VE, Lorch JA, Shukla R, Satwah S. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. BMC Nephrol. 2009;10:6. PMID: 19245700. Pubmed Central PMCID: 2671502. doi: 10.1186/1471-2369-10-6
10. Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant. 2004;19(Suppl 2):ii1-ii47. PMID: 15206425
11. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006;47(5 Suppl 3):S11-145. PMID: 16678659.
12. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl. 2012;2(4):279-335. PMID: 25018949. Pubmed Central PMCID: 4089602.
13. Nakai S, Masakane I, Shigematsu T, Hamano T, Yamagata K, Watanabe Y, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial. 2009;13(6):457-504. PMID: 19954472. doi: 10.1111/j.1744-9987.2009.00789.x
14. McFarlane PA, Pisoni RL, Eichleay MA, Wald R, Port FK, Mendelssohn D. International trends in erythropoietin use and hemoglobin levels in hemodialysis patients. Kidney Int. 2010;78(2):215-23. PMID: 20428102. doi: 10.1038/ki.2010.108
15. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(1):94-111. PMID: 15211443.
16. Bailie GR, Larkina M, Goodkin DA, Li Y, Pisoni RL, Bieber B, et al. Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2013;28(10):2570-9. PMID: 24078642. doi: 10.1093/ndt/gft062
17. Ichii H, Masuda Y, Hassanzadeh T, Saffarian M, Gollapudi S, Vaziri ND. Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes. Am J Nephrol. 2012;36(1):50-7. PMID: 22722756. Pubmed Central PMCID: 3986045. doi: 10.1159/000339285
18. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. Bmj. 2013;347:f4822. PMID: 23950195. Pubmed Central PMCID: 3805480. doi: 10.1136/bmj.f4822
19. Ishida JH, Johansen KL. Iron and infection in hemodialysis patients. Semin Dial. 2014;27(1):26-36. PMID: 24329610. Pubmed Central PMCID: 4016233. doi: 10.1111/sdi.12168
20. Galic G, Tomic M, Galesic K, Kvesic A, Soljic M, Londar Z, et al. The etiological relation between serum iron level and infection incidence in hemodialysis uremic patients. Collegium antropologicum. 2011;35(1):93-101. PMID: 21667534.
21. Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol. 2006;1 Suppl 1:S9-18. PMID: 17699375.
22. Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, et al. Low hemoglobin levels and hyporesponsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients. Ther Apher Dial. 2014;18(5):404-13. PMID: 24571446. doi: 10.1111/1744-9987.12155
23. Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol. 2005;16(7):2180-9. PMID: 15901766.
24. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339(9):584-90. PMID: 9718377.
25. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, et al. Meta-analysis: erythropoiesisstimulating agents in patients with chronic kidney disease. Ann Intern Med. 2010;153(1):23-33. PMID: 20439566. doi: 10.7326/0003-4819-153-1-201007060-00252
26. Li S, Foley RN, Collins AJ. Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States. Kidney Int. 2004;65(5):1864-9. PMID: 15086928.
27. Molnar MZ, Mehrotra R, Duong U, Kovesdy CP, Kalantar-Zadeh K. Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011;6(8):1973-81. PMID: 21784829. Pubmed Central PMCID: 3359540. doi: 10.2215/CJN.01050211
28. Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, Bradbury BD, et al. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: A retrospective cohort analysis. Am J Nephrol. 2015;41(4-5):354-61. PMID: 26107376. doi: 10.1159/000431335
29. House AA, Pham B, Page DE. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities. Nephrol Dial Transplant. 1998;13(7):1763-9. PMID: 9681725.
30. Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, et al. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis. Journal of nephrology. 2003;16(5):697-702. PMID: 14733416.